Abstracts by key term: Tumor centers
The “National Cancer Plan” from BMG, DKH and DKG reads like a 5-year plan to generate enormous needs, especially in the area of medication, to ensure that the increasing amounts of substances in the “oncological drug market” are supplied to a sufficiently increasing number of “consumers”. and that they are also prepared to pay the prices demanded by the product manufacturers, no matter how high, without ever being able to receive proof of benefit. A national cancer plan that serves the well-being of the individual affected and the population as a whole must pursue the opposite goal of the growth of disease and suffering: it must reduce the risk of disease, reduce the burden of disease and lead to a reduction in cancer incidence and cancer mortality through a variety of preventive measures. With such a national cancer (prevention) plan, the profit expectations of the oncological pharmaceutical market would not be fulfilled in the next 5 to 10 years. In return, the quality of life and life expectancy of the population in Germany would increase significantly. On such a central question of democracy, citizens in Germany must be asked which national cancer plan they want.